Key result
Implantable cardioverter-defibrillators remain the only effective intervention to reduce mortality in Brugada syndrome, making accurate arrhythmic risk stratification the primary focus of clinical management.
Highlights the diagnostic pathway from non-specific symptoms like palpitations to the identification of Brugada syndrome and subsequent ICD implantation.
Answers are grounded in this paper and cite their sources.
Supports symptom-driven Brugada diagnosis in practice; leaves open optimal risk stratification tools.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Comelli et al. (2010) conducted a review in Brugada syndrome. Implantable cardioverter-defibrillator (ICD) was evaluated. Implantable cardioverter-defibrillators remain the only effective intervention to reduce mortality in Brugada syndrome, making accurate arrhythmic risk stratification the primary focus of clinical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: